| 1 |
Du X, Liu Q, Li Q, et al. Prognostic value of cerebral infarction coefficient in patients with massive cerebral infarction [J]. Clin Neurol Neurosurg, 2020, 196: 106009.
|
| 2 |
He WT, Wan H, Hu L, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion [J]. Cell Res, 2015, 25(12): 1285-1298.
|
| 3 |
Ning W, Acharya A, Li S, et al. Identification of key pyroptosis-related genes and distinct pyroptosis-related clusters in periodontitis [J]. Front Immunol, 2022, 13: 862049.
|
| 4 |
Wang S, Liao X, Xiong X, et al. Pyroptosis in urinary malignancies: a literature review [J]. Discov Oncol, 2023, 14(1): 12.
|
| 5 |
李欢, 唐旭东. GSDME介导的细胞焦亡在肺癌治疗中作用的研究进展 [J]. 中国肺癌杂志, 2024, 27(7): 529-534.
|
| 6 |
Song R, He S, Wu Y, et al. Pyroptosis in sepsis induced organ dysfunction [J]. Curr Res Transl Med, 2024, 72(2): 103419.
|
| 7 |
Zhu C, Liang Y, Luo Y, et al. Role of pyroptosis in hemostasis activation in sepsis [J]. Front Immunol, 2023, 14: 1114917.
|
| 8 |
Wan T, Li X, Li Y. The role of TRIM family proteins in autophagy, pyroptosis, and diabetes mellitus [J]. Cell Biol Int, 2021, 45(5): 913-926.
|
| 9 |
Wang W, Wang Y. Integrative bioinformatics analysis of biomarkers and pathways for exploring the mechanisms and molecular targets associated with pyroptosis in type 2 diabetes mellitus [J]. Front Endocrinol (Lausanne), 2023, 14: 1207142.
|
| 10 |
Zhang X, Zhang Y, Wang B, et al. Pyroptosis-mediator GSDMD promotes Parkinson's disease pathology via microglial activation and dopaminergic neuronal death [J]. Brain Behav Immun, 2024, 119: 129-145.
|
| 11 |
Xu YJ, Zheng L, Hu YW, et al. Pyroptosis and its relationship to atherosclerosis [J]. Clin Chim Acta, 2018, 476: 28-37.
|
| 12 |
Zhang Z, Liu S, Huang S. Effects of thymosin β4 on neuronal apoptosis in a rat model of cerebral ischemia-reperfusion injury [J]. Mol Med Rep, 2019, 20(5): 4186-4192.
|
| 13 |
刘嘉, 刘云婷, 鱼童, 等. 清热开窍方激活Nrf2/HO-1信号通路抑制细胞焦亡治疗大鼠缺血性脑卒中 [J]. 中医学报, 2025, 40(9): 1960-1967.
|
| 14 |
Liu X, Bai M, Fan L, et al. Serum 4-hydroxynonenal associates with the recurrence of patients with primary cerebral infarction [J]. Front Cell Neurosci, 2022, 16: 998512.
|
| 15 |
Wu S, Wu BO, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management [J]. Lancet Neurol, 2019, 18(4): 394-405.
|
| 16 |
Shang YX, Yan LF, Cornett EM, et al. Incidence of cerebral infarction in Northwest China from 2009 to 2018 [J]. Cureus, 2021, 13(8): e17576.
|
| 17 |
Hasan TF, Hasan H, Kelley RE. Overview of acute ischemic stroke evaluation and management [J]. Biomedicines, 2021, 9(10): 1486.
|
| 18 |
Dong X, Xu G, Song Y, et al. Comparative study on treatment of acute cerebral infarction between mechanical thrombectomy by micro catheter and thrombectomy by Solitaire AB stent [J]. Medicine, 2022, 101(14): e28968.
|
| 19 |
Liu Y, Hong Z, Li Y, et al. Effect of intravenous thrombolysis combined with mechanical thrombectomy on neurological function and short-term prognosis of patients with acute cerebral infarction [J]. Am J Transl Res, 2022, 14(4): 2376.
|
| 20 |
Zhao QS, Li W, Li D, et al. Clinical treatment efficiency of mechanical thrombectomy combined with rhPro-UK thrombolysis for acute moderate/severe cerebral infarction [J]. Eur Rev Med Pharmacol Sci, 2018, 22(17): 5740-5746.
|
| 21 |
Ran YC, Zhu M, Li SJ, et al. Related research and recent progress of ischemic penumbra [J]. World Neurosurg, 2018, 116: 5-13.
|
| 22 |
Shen Z, Lu Y, Ren Y, et al. The relationship between ischemic penumbra progression and the oxygen content of cortex microcirculation in acute ischemic stroke [J]. Neurotherapeutics, 2024, 21(5): e00387.
|
| 23 |
Zhu X, Zhang K, Lu K, et al. Inhibition of pyroptosis attenuates Staphylococcus aureus-induced bone injury in traumatic osteomyelitis [J]. Ann Transl Med, 2019, 7(8): 170.
|
| 24 |
Hu S, Lin T, Chen Y, et al. NLRC4‐mediated pyroptosis was involved in coagulation disorders of acute pancreatitis [J]. J Gene Med, 2024, 26(4): e3683.
|
| 25 |
Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 [J]. Cell Death Differ, 2018, 25(3): 486-541.
|
| 26 |
Gong W, Shi Y, Ren J. Research progresses of molecular mechanism of pyroptosis and its related diseases [J]. Immunobiology, 2020, 225(2): 151884.
|
| 27 |
Fang Y, Tian S, Pan Y, et al. Pyroptosis: a new frontier in cancer [J]. Biomed Pharmacother, 2020, 121: 109595.
|
| 28 |
Cao Z, Huang D, Tang C, et al. Pyroptosis in diabetes and diabetic nephropathy [J]. Clin Chim Acta, 2022, 531: 188-196.
|
| 29 |
Rao Z, Zhu Y, Yang P, et al. Pyroptosis in inflammatory diseases and cancer [J]. Theranostics, 2022, 12(9): 4310-4329.
|
| 30 |
Zheng Z, Li G. Mechanisms and therapeutic regulation of pyroptosis in inflammatory diseases and cancer [J]. Int J Mol Sci, 2020, 21(4): 1456.
|
| 31 |
Liang S, Xu L, Xin X, et al. Study on pyroptosis-related genes Casp8, Gsdmd and Trem2 in mice with cerebral infarction [J]. PeerJ, 2024, 12: e16818.
|
| 32 |
Li W, Shen N, Kong L, et al. STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke [J]. Stroke Vasc Neurol, 2024, 9(2): 153-164.
|
| 33 |
纳子寒, 马妍, 白慧梅. 基于细胞焦亡探讨中药干预缺血性卒中的药理机制研究进展 [J]. 环球中医药, 2025, 18(3): 622-628.
|
| 34 |
Zhang X, Sang X, Chen Y, et al. VCAM-1+hUC-MSCs exert considerable neuroprotection against cerebral infarction in rats by suppression of NLRP3-induced pyroptosis [J]. Neurochem Res, 2023, 48(10): 3084-3098.
|
| 35 |
Huang L, Li X, Liu Y, et al. Curcumin alleviates cerebral ischemia-reperfusion injury by inhibiting NLRP1-dependent neuronal pyroptosis [J]. Curr Neurovasc Res, 2021, 18(2): 189-196.
|
| 36 |
宋行行, 刘鑫源, 李虹霖, 等. 细胞焦亡在脑缺血再灌注损伤中作用机制的研究进展 [J]. 生命科学, 2025, 37(3): 296-303.
|
| 37 |
Zhao M, Xian W, Liu W, et al. Maresin1 alleviates neuroinflammation by inhibiting caspase-3/ GSDME-mediated pyroptosis in mice cerebral ischemia-reperfusion model [J]. J Stroke Cerebrovasc, 2024, 33(8): 107789.
|
| 38 |
Yang L, Gao Y, Huang J, et al. LncRNA Gm44206 promotes microglial pyroptosis through NLRP3/Caspase-1/GSDMD axis and aggravate cerebral ischemia-reperfusion injury [J]. DNA Cell Biol, 2023, 42(9): 554-562.
|
| 39 |
Zhou S, Bao J, Wang Y, et al. S100β as a biomarker for differential diagnosis of intracerebral hemorrhage and ischemic stroke [J]. Neurol Res, 2016, 38(4): 327-332.
|
| 40 |
Choi JI, Ha SK, Lim DJ, et al. S100ß, matrix metalloproteinase-9, D-dimer, and heat shock protein 70 are serologic biomarkers of acute cerebral infarction in a mouse model of transient MCA occlusion [J]. J Korean Neurosurg Soc, 2018, 61(5): 548-558.
|
| 41 |
Floerchinger B, Philipp A, Camboni D, et al. NSE serum levels in extracorporeal life support patients—Relevance for neurological outcome [J]. Resuscitation, 2017, 121: 166-171.
|
| 42 |
张春瑞, 尉建辉. 血清S100β、Aβ及NSE联合检测可提高急性脑梗死脑侧支循环建立的预测效能 [J]. 内科急危重症杂志, 2024, 30(6): 542-544, 564.
|
| 43 |
Yuan X, Wang J, Wang D, et al. NSE, S100B and MMP9 expression following reperfusion after carotid artery stenting [J]. Curr Neurovascular Res, 2019, 16(2): 129-134.
|
| 44 |
李小磊, 高刘炯, 苏军. BIS、RSO2联合血清S100β、NSE水平评估急性脑损伤患儿病情严重程度及预后的价值 [J]. 临床医学, 2024, 44(6): 15-18.
|